Nano Interface Technology Announces Evaluation of its Products in Collaboration with NRL and VCU -- Expanding the Market Success of Nano-Biomaterials Coated Orthopedic and Dental Implants

    LORTON, Va., April 13 /PRNewswire/ -- Nano Interface Technology, Inc.
 (NITI) announces evaluation of its product in collaboration with the Naval
 Research Laboratory (NRL) and the Virginia Commonwealth University (VCU).
 These leading institutions involved in nanotechnology research are working
 with the Nano Interface Technology to examine a variety of
 nano-biomaterials for coating of orthopedic/dental implants and other
     NITI has signed a Corporate Research and Development Agreement (CRADA)
 with NRL related to coatings for orthopedic implants. The collaboration
 with VCU will address innovative dental applications.
     "We are very pleased to sign a CRADA with the NRL because NRL is a
 pioneer research organization in nanotechnology and has contributed very
 significantly in the development of several nanotechnology-based products.
 NITI continues to develop products using its proprietary platform
 technology; its products are examined through relationships with top
 government and academic institutions. The new products assessment
 relationships are solidifying our leadership in commercializing ultra-pure
 nano-biomaterials for orthopedic and dental applications," stated Dr. C. P.
 Singh, President & CEO at Nano Interface Technology. "In the nanotechnology
 arena, only those companies which have slow and steady growth will win the
 race," he added.
     "The collaboration with Nano Interface Technology will accelerate
 development of better products for orthopedic and dental applications,"
 stated Dr. Peter C. Moon, Director of Dental Biomaterials Laboratory at the
 Virginia Commonwealth University.
     About Nano Interface Technology, Inc.
     NITI is launching a portfolio of products based on ultra-pure nano-
 biomaterials for medical devices such as hip, knee and dental implants.
 These nano-biomaterials based devices are scalable and use ultra-pure nano-
 biomaterials developed using proprietary platform technology. These nano-
 biomaterials can be applied to a broad range of medical applications where
 the purity, strength and perfect biocompatibility of biomaterials are
 paramount for the success rate of such products.

SOURCE Nano Interface Technology, Inc.

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.


PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.